98 results on '"O'Rourke, Robert A."'
Search Results
2. Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study
3. MDCT imaging in Spigelian hernia, clinical, and surgical implications
4. Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes
5. Adipose tissue and the physiologic underpinnings of metabolic disease
6. Weight loss independent changes in adipose tissue macrophage and T cell populations after sleeve gastrectomy in mice
7. Preoperative factors and 3-year weight change in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium
8. Obesity and cancer: at the crossroads of cellular metabolism and proliferation
9. Reporting weight change: standardized reporting accounting for baseline weight
10. Inflammation, obesity, and the promise of immunotherapy for metabolic disease
11. Prevalence of Adverse Intraoperative Events during Obesity Surgery and Their Sequelae
12. Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice
13. Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial)
14. Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
15. Comparison of 30-day outcomes after non-LapBand primary and revisional bariatric surgical procedures from the Longitudinal Assessment of Bariatric Surgery study
16. β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing
17. Mitral Valve Prolapse With a Late-Systolic Regurgitant Murmur May Be Associated With Significant Hemodynamic Consequences
18. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease
19. Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial
20. Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)
21. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
22. Optimal Medical Therapy Is a Proven Option for Chronic Stable Angina
23. ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
24. Revisional bariatric surgery for failed restrictive procedures
25. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
26. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
27. Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424
28. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on Cardiac Catheterization Laboratory Standards : A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents endorsed by the American Heart Association and the Diagnostic and Interventional Catheterization Committee of the Council on Clinical Cardiology of the AHA
29. Chapter 18 - Laparoscopic and Open Nissen Fundoplication
30. Post–myocardial infarction β-blocker therapy: The bradycardia conundrum. Rationale and design for the Pacemaker & β-blocker therapy post-MI (PACE-MI) trial
31. The Evolving Pattern of Symptomatic Coronary Artery Disease in the United States and Canada: Baseline Characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial
32. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial
33. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive Dru G Evaluation (COURAGE) trial : Veterans Affairs Cooperative Studies Program no. 424
34. Endometrial hyperplasia, endometrial cancer, and obesity: convergent mechanisms regulating energy homeostasis and cellular proliferation
35. An emerging role for bone in interorgan communication and the pathogenesis of metabolic disease
36. Contributors
37. HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL IS ASSOCIATED WITH RESIDUAL RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DESPITE OPTIMAL LEVELS OF LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL: A POST HOC ANALYSIS FROM THE COURAGE TRIAL
38. A NEW RISK PREDICTION TOOL TO ASSESS LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE (SIHD): THE “COURAGE RISK SCORE”
39. Prevalence of Adverse Intraoperative Events During Obesity Surgery and Their Sequelae
40. The Corrected Values for Duration and Frequency of Angina at Baseline in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial
41. 1006-57 Atherosclerotic plaque can be quantified using multifractal and wavelet decomposition techniques
42. 1154-85 High incidence of the metabolic syndrome in symptomatic coronary heart disease in North America during the early 21st century
43. 10: Laparoscopic Placement of Hepatic Artery Infusion Pump: Technical Considerations and Perioperative Complications
44. Guidelines for clinical use of cardiac radionuclide imaging: A report of the american college of cardiology/american heart association task force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on radionuclide imaging)—developed in collaboration with the american society of nuclear cardiology
45. ACC/AHA task force report special report: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: Report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on perioperative cardiovascular evaluation for noncardiac surgery)
46. Overview of trends in heart disease changing prognosis after myocardial infarction
47. The Role of Cardiac Catheterization in Patients after Myocardial Infarction
48. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Clinical Intracardiac electrophysiologic and catheter ablation procedures), developed in collaboration with the North American Society of pacing and electrophysiology
49. Effect of digoxin and vasodilators on left ventricular function in aortic regurgitation
50. Diltiazem: effects on exercise performance in patients with coronary artery disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.